Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01300832
Other study ID # 10-589-A
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2011
Est. completion date December 1, 2022

Study information

Verified date June 2023
Source University of Chicago
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study's hypothesis is that there are some patients who come for surgery who have asymptomatic clots in their lower extremities upon their arrival to the hospital for their surgical admission. We will be performing duplex studies of the subjects' legs before their surgery to determine how often clots are present. We will also perform duplex scans of the legs after the subjects' surgeries to determine what factors (surgical, anesthetic, co-morbidities)are correlated with the development of DVTs.


Recruitment information / eligibility

Status Completed
Enrollment 271
Est. completion date December 1, 2022
Est. primary completion date December 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18+ and consentable Exclusion Criteria: - Anticoagulation therapy or known DVT

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Duplex scan of lower extremities
Lower extremities will be duplex scanned pre and post-operatively

Locations

Country Name City State
United States University of Chicago Hospitals Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of preoperative DVTs Day of surgery
Primary Incidence of post-operative DVTs Within 48 hours of surgery
Secondary Risk factors associated with the development of perioperative DVTs Within 180 days of surgery
Secondary Distribution and laterality Level and laterality of clots that develop and association of these with risk factors Within 180 days of surgery
Secondary Risks associated with perioperative DVTs Association of clinical pulmonary emboli and/or cardiac arrests, cerebral vascular events, or other causes of death or significant morbidities (e.g., post-op pneumonias or other infections)perioperatively with DVTs Within 180 days of surgery